Literature DB >> 28467878

The Failure of Solanezumab - How the FDA Saved Taxpayers Billions.

Chana A Sacks1, Jerry Avorn1, Aaron S Kesselheim1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28467878     DOI： 10.1056/NEJMp1701047

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

Review 1.  Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be "extraordinarily diverse".

Authors:  Madhav Thambisetty
Journal:  Am J Physiol Cell Physiol       Date:  2017-06-14       Impact factor: 4.249

Review 2.  Neuroimaging in Dementia.

Authors:  Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2017-12-05       Impact factor: 3.420

3.  A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice.

Authors:  Shuyu Liu; Fujiko Ando; Yu Fujita; Junjun Liu; Tomoji Maeda; Xuefeng Shen; Kota Kikuchi; Aoi Matsumoto; Mirai Yokomori; Chiaki Tanabe-Fujimura; Hiroshi Shimokata; Makoto Michikawa; Hiroto Komano; Kun Zou
Journal:  J Biol Chem       Date:  2019-05-09       Impact factor: 5.157

Review 4.  Impact of Genetic Risk Factors for Alzheimer's Disease on Brain Glucose Metabolism.

Authors:  Sukhee Cho; Hyein Lee; Jinsoo Seo
Journal:  Mol Neurobiol       Date:  2021-01-21       Impact factor: 5.590

Review 5.  Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer's Disease.

Authors:  Tamas Fulop; Shreyansh Tripathi; Serafim Rodrigues; Mathieu Desroches; Ton Bunt; Arnold Eiser; Francois Bernier; Pascale B Beauregard; Annelise E Barron; Abdelouahed Khalil; Adam Plotka; Katsuiku Hirokawa; Anis Larbi; Christian Bocti; Benoit Laurent; Eric H Frost; Jacek M Witkowski
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-04       Impact factor: 2.570

6.  Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease.

Authors:  Tamàs Fülöp; Usma Munawara; Anis Larbi; Mathieu Desroches; Serafim Rodrigues; Michele Catanzaro; Andrea Guidolin; Abdelouahed Khalil; François Bernier; Annelise E Barron; Katsuiku Hirokawa; Pascale B Beauregard; David Dumoulin; Jean-Philippe Bellenger; Jacek M Witkowski; Eric Frost
Journal:  CNS Drugs       Date:  2020-07       Impact factor: 6.497

Review 7.  Dual-therapy strategy for modification of adiponectin receptor signaling in aging-associated chronic diseases.

Authors:  Masaaki Waragai; Gilbert Ho; Yoshiki Takamatsu; Yuka Shimizu; Hiromu Sugino; Shuei Sugama; Takato Takenouchi; Eliezer Masliah; Makoto Hashimoto
Journal:  Drug Discov Today       Date:  2018-05-07       Impact factor: 7.851

Review 8.  Structure and Function of Alzheimer's Amyloid βeta Proteins from Monomer to Fibrils: A Mini Review.

Authors:  Nikhil Agrawal; Adam A Skelton
Journal:  Protein J       Date:  2019-08       Impact factor: 2.371

Review 9.  The Role of Genetics in Advancing Precision Medicine for Alzheimer's Disease-A Narrative Review.

Authors:  Yun Freudenberg-Hua; Wentian Li; Peter Davies
Journal:  Front Med (Lausanne)       Date:  2018-04-24

Review 10.  Can an Infection Hypothesis Explain the Beta Amyloid Hypothesis of Alzheimer's Disease?

Authors:  Tamas Fulop; Jacek M Witkowski; Karine Bourgade; Abdelouahed Khalil; Echarki Zerif; Anis Larbi; Katsuiku Hirokawa; Graham Pawelec; Christian Bocti; Guy Lacombe; Gilles Dupuis; Eric H Frost
Journal:  Front Aging Neurosci       Date:  2018-07-24       Impact factor: 5.750
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.